Recommendations for Uniform Variant Calling of SARS-CoV-2 Genome Sequence across Bioinformatic Workflows

• Published in: Viruses Vol. 16; no. 3; p. 430
• Main Authors: Connor, Ryan, Shakya, Migun, Yarmosh, David A., Maier, Wolfgang, Martin, Ross, Bradford, Rebecca, Brister, J. Rodney, Chain, Patrick S. G., Copeland, Courtney A., di Iulio, Julia, Hu, Bin, Ebert, Philip, Gunti, Jonathan, Jin, Yumi, Katz, Kenneth S., Kochergin, Andrey, LaRosa, Tré, Li, Jiani, Li, Po-E, Lo, Chien-Chi, Rashid, Sujatha, Maiorova, Evguenia S., Xiao, Chunlin, Zalunin, Vadim, Purcell, Lisa, Pruitt, Kim D.
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 11.03.2024; MDPI
• Subjects: 60 APPLIED LIFE SCIENCES; Analysis; bioinformatics; Biotechnology; Computational Biology; COVID-19; COVID-19 - epidemiology; COVID-19 infection; COVID-19 vaccines; data collection; Datasets; DNA sequencing; Evaluation; Genetic diversity; genome; Genomes; genomics; Humans; industry; monitoring; Mutation; nanopores; Nucleotide sequence; nucleotide sequences; Nucleotide sequencing; pandemic; Pandemics; pathogens; Public health; Public health administration; SARS-CoV-2; SARS-CoV-2 - genetics; Severe acute respiratory syndrome coronavirus 2; Single-nucleotide polymorphism; Software; vaccines; variant calling; Virology; viruses; Whole genome sequencing; Workflow; United States; SARS-CoV-2; variant calling
• ISSN: 1999-4915; 1999-4915
• DOI: 10.3390/v16030430

Genomic sequencing of clinical samples to identify emerging variants of SARS-CoV-2 has been a key public health tool for curbing the spread of the virus. As a result, an unprecedented number of SARS-CoV-2 genomes were sequenced during the COVID-19 pandemic, which allowed for rapid identification of genetic variants, enabling the timely design and testing of therapies and deployment of new vaccine formulations to combat the new variants. However, despite the technological advances of deep sequencing, the analysis of the raw sequence data generated globally is neither standardized nor consistent, leading to vastly disparate sequences that may impact identification of variants. Here, we show that for both Illumina and Oxford Nanopore sequencing platforms, downstream bioinformatic protocols used by industry, government, and academic groups resulted in different virus sequences from same sample. These bioinformatic workflows produced consensus genomes with differences in single nucleotide polymorphisms, inclusion and exclusion of insertions, and/or deletions, despite using the same raw sequence as input datasets. Here, we compared and characterized such discrepancies and propose a specific suite of parameters and protocols that should be adopted across the field. Consistent results from bioinformatic workflows are fundamental to SARS-CoV-2 and future pathogen surveillance efforts, including pandemic preparation, to allow for a data-driven and timely public health response.